Nova Patents
EP2484751A2

Method of analysing polynucleotides

Abstract

The present invention relates to a device for interfacing nanofluidic and microfluidic components suitable for use in performing high throughput macromolecular analysis. Diffraction gradient lithography (DGL) is used to form a gradient interface between a microfluidic area and a nanofluidic area. The gradient interface area reduces the local entropic barrier to anochannels formed in the nanofluidic area. In one embodiment, the gradient interface area is formed of lateral spatial gradient structures for narrowing the cross section of a value from the micron to the nanometer length scale. In another embodiment, the gradient interface area is formed of a vertical sloped gradient structure. Additionally, the gradient structure can provide both a lateral and vertical gradient.

EP2484751A2, drawing sheet 1
Sheet 1 of 17

Term

Term ended

Projected expiry passed 16 April 2023, 3.4 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

15 claims: 1 independent, 14 dependent

  1. 1
    A method for analyzing polynucleotide macromolecules, comprising:providing a device having a nanofluidic area in fluid communication with a microfluidic area, the nanofluidic area comprising a plurality of nanofluidic channels;introducing polynucleotide macromolecules into the microfluidic area, where the polynucleotides are at least partially coiled in the microfluidic area;elongating the polynucleotides and transporting the polynucleotides from the microfluidic area into the nanofluidic channels, wherein the nanofluidic channels have dimensions that maintain the polynucleotides in an elongated form;and detecting signals indicative of at least one property of elongated polynucleotides in the nanofluidic channels.
  2. 2
    The method of Claim 1, wherein:elongating the polynucleotides comprises transporting the polynucleotides through a gradient area linking the microfluidic area and the nanofluidic area, wherein the gradient area includes structure to mechanically elongate the polynucleotides prior to transporting the polynucleotides into the nanofluidic channels.
  3. 3
    The method of Claim 2, further comprising:labeling the polynucleotides with a detectable label prior to transporting the polynucleotides into the nanofluidic channels.
  4. 4
    The method of Claim 3, wherein the detectable label is a fluorescent label.
  5. 5
    The method of any of Claims 1-4, wherein the polynucleotides have an elongated length in the channels of greater than 150 nanometers.
  6. 6
    The method of any of Claims 1-4, wherein the polynucleotides have an elongated length in the channels of greater than 500 nanometers.
  7. 7
    The method of any of Claims 1-4, wherein the polynucleotides have an elongated length in the channels of greater than 1 micron.
  8. 8
    The method of any of Claims 1-7, wherein the detected signal is correlated to a sequence of a polynucleotide.
  9. 9
    The method of any of Claims 1-7, wherein the detected signal is correlated to at least one of the length, conformation, and physical or chemical attachment such as a bound marker or tagging.
  10. 10
    The method of any of Claims 1-9, wherein the polynucleotides are DNA.
  11. 11
    The method of any of Claims 1-9, wherein the polynucleotides are RNA.
  12. 12
    The method of any of Claims 1-11, wherein the polynucleotides are at least substantially unfolded in the nanofluidic channels.
  13. 13
    The method of any of Claims 1-12, wherein the polynucleotides have greater than 1000 base pairs.
  14. 14
    The method of any of Claims 1-12, wherein the polynucleotides have greater than 1,000,000 base pairs.
  15. 15
    The method of any of Claims 1-12, wherein at least one of said polynucleotides is a chromosome, and the method comprises determining the presence of at least one single nucleotide polymorphism.